Michelle M. Martinez-Montemayor
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reishi | 2 | 2013 | 6 | 0.870 |
Why?
|
| 6-Phytase | 3 | 2008 | 3 | 0.850 |
Why?
|
| Zinc | 3 | 2008 | 114 | 0.780 |
Why?
|
| Antineoplastic Agents | 4 | 2019 | 756 | 0.700 |
Why?
|
| Zingiberales | 1 | 2015 | 1 | 0.550 |
Why?
|
| Metallothionein | 2 | 2005 | 21 | 0.510 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 152 | 0.480 |
Why?
|
| Blood Glucose | 1 | 2015 | 333 | 0.470 |
Why?
|
| Neoplasm Metastasis | 2 | 2011 | 211 | 0.440 |
Why?
|
| Plant Extracts | 1 | 2015 | 250 | 0.440 |
Why?
|
| Dietary Supplements | 4 | 2012 | 196 | 0.430 |
Why?
|
| Liver | 3 | 2008 | 447 | 0.380 |
Why?
|
| Isoflavones | 2 | 2012 | 125 | 0.380 |
Why?
|
| Genistein | 1 | 2010 | 41 | 0.370 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2012 | 781 | 0.350 |
Why?
|
| Cell Line, Tumor | 7 | 2019 | 2128 | 0.280 |
Why?
|
| Blotting, Western | 3 | 2013 | 834 | 0.260 |
Why?
|
| Intestinal Mucosa | 1 | 2004 | 115 | 0.230 |
Why?
|
| Eukaryotic Initiation Factor-4G | 2 | 2012 | 11 | 0.210 |
Why?
|
| Weaning | 3 | 2008 | 15 | 0.210 |
Why?
|
| Swine | 3 | 2008 | 182 | 0.200 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 550 | 0.200 |
Why?
|
| RNA, Messenger | 2 | 2012 | 1152 | 0.200 |
Why?
|
| Ergosterol | 1 | 2019 | 10 | 0.180 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 968 | 0.170 |
Why?
|
| Fluorescent Dyes | 1 | 2019 | 173 | 0.160 |
Why?
|
| Animals | 8 | 2015 | 14307 | 0.160 |
Why?
|
| Cladribine | 1 | 2015 | 3 | 0.140 |
Why?
|
| Guanosine | 1 | 2015 | 27 | 0.140 |
Why?
|
| Mice | 4 | 2015 | 5668 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2012 | 52 | 0.130 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2015 | 224 | 0.120 |
Why?
|
| Neoplasm Transplantation | 2 | 2012 | 114 | 0.120 |
Why?
|
| Mice, Nude | 2 | 2012 | 323 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2019 | 1149 | 0.110 |
Why?
|
| Phytoestrogens | 1 | 2012 | 35 | 0.110 |
Why?
|
| Female | 6 | 2013 | 19873 | 0.110 |
Why?
|
| DNA Primers | 1 | 2013 | 269 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 123 | 0.110 |
Why?
|
| Kidney | 2 | 2005 | 322 | 0.110 |
Why?
|
| Catenins | 1 | 2011 | 3 | 0.100 |
Why?
|
| bcl-X Protein | 1 | 2011 | 23 | 0.100 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 72 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 185 | 0.100 |
Why?
|
| Cadherins | 1 | 2011 | 82 | 0.100 |
Why?
|
| Base Sequence | 1 | 2013 | 932 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 1530 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 859 | 0.100 |
Why?
|
| Puerto Rico | 1 | 2015 | 1352 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 247 | 0.090 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2009 | 21 | 0.090 |
Why?
|
| Catechin | 1 | 2009 | 30 | 0.090 |
Why?
|
| Expressed Sequence Tags | 1 | 2008 | 24 | 0.080 |
Why?
|
| Humans | 7 | 2019 | 34853 | 0.080 |
Why?
|
| Vitis | 1 | 2009 | 29 | 0.080 |
Why?
|
| Bone Neoplasms | 1 | 2009 | 42 | 0.080 |
Why?
|
| Quercetin | 1 | 2009 | 41 | 0.080 |
Why?
|
| Stilbenes | 1 | 2009 | 41 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 605 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2009 | 70 | 0.080 |
Why?
|
| Cell Survival | 1 | 2011 | 818 | 0.080 |
Why?
|
| Disease Progression | 1 | 2010 | 580 | 0.080 |
Why?
|
| Spatial Behavior | 1 | 2006 | 22 | 0.070 |
Why?
|
| Discrimination Learning | 1 | 2006 | 27 | 0.070 |
Why?
|
| Apoptosis | 2 | 2011 | 1317 | 0.070 |
Why?
|
| Exploratory Behavior | 1 | 2006 | 72 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 1490 | 0.070 |
Why?
|
| Jejunum | 1 | 2005 | 8 | 0.070 |
Why?
|
| Zinc Oxide | 1 | 2005 | 16 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 600 | 0.060 |
Why?
|
| Intestinal Absorption | 1 | 2004 | 19 | 0.060 |
Why?
|
| Copper | 1 | 2005 | 101 | 0.060 |
Why?
|
| Male | 3 | 2015 | 18870 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2006 | 522 | 0.060 |
Why?
|
| Hippocampus | 1 | 2006 | 546 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2008 | 874 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 1426 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2006 | 653 | 0.050 |
Why?
|
| Time Factors | 1 | 2005 | 1681 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 107 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2019 | 150 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2019 | 240 | 0.040 |
Why?
|
| Leukemia, Hairy Cell | 1 | 2015 | 3 | 0.030 |
Why?
|
| Lymphoma, T-Cell | 1 | 2015 | 25 | 0.030 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 18 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 81 | 0.030 |
Why?
|
| Organophosphorus Compounds | 1 | 2015 | 36 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 376 | 0.030 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2012 | 14 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2012 | 25 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 87 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2012 | 490 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2009 | 309 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2006 | 3 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2006 | 38 | 0.020 |
Why?
|
| Space Perception | 1 | 2006 | 31 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2006 | 86 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 106 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2009 | 306 | 0.020 |
Why?
|
| Extinction, Psychological | 1 | 2006 | 89 | 0.020 |
Why?
|
| Memory | 1 | 2006 | 165 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2006 | 528 | 0.020 |
Why?
|
| Rats | 1 | 2006 | 3261 | 0.010 |
Why?
|